Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Industry criticizes India's reliance on drug importers for ADR-related action

This article was originally published in SRA

Executive Summary

India has underscored the significance of proactive reporting by drug importers of adverse reaction-related "administrative action" of foreign regulators as part of the country's efforts to improve regulatory compliance1.